Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis to Open Data on Newly Approved Medicines to Researchers
Bloomberg
Wednesday, February 26, 2014 - 9:09am
tags:
Novartis, drug approvals, R&D, clinical trial data
Orexigen Sees Positives In European Application For Contrave
Seeking Alpha
Wednesday, February 26, 2014 - 9:08am
tags:
Contrave, Europe, obesity, Orexigen
Arena Pharmaceuticals, Inc. Earnings: What to Expect Thursday
Motley Fool
Wednesday, February 26, 2014 - 9:07am
tags:
earnings, Arena Pharmaceuticals
Bayer says takeover offer for Algeta successful
Reuters
Wednesday, February 26, 2014 - 9:05am
tags:
Bayer, Algeta, M&A
NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule
TheStreet.com
Wednesday, February 26, 2014 - 9:04am
tags:
pancreatic cancer, vaccine, HyperAcute Pancreas, NewLink Genetics
Tiny Northwest Biotherapeutics aims to dominate brain cancer
Yahoo/Reuters
Wednesday, February 26, 2014 - 8:41am
tags:
Northwest Biotherapeutics, DCVax-L, brain cancer
Merck Abandons Once-Promising Experimental Cancer Drug to Ariad
Wall St Cheat Sheet
Tuesday, February 25, 2014 - 6:15pm
tags:
Merck, Ariad Pharmaceuticals, ridaforolimus
FDA approves Anika Therapeutics arthritis drug
Yahoo/Reuters
Tuesday, February 25, 2014 - 6:14pm
tags:
Anika, FDA, osteoarthritis of the knee, Monovisc, DePuy, JNJ
AbbVie, Amgen and Roche most vulnerable to biosim rivals, Moody's says
Fierce Pharma
Tuesday, February 25, 2014 - 3:58pm
tags:
AbbVie, Amgen, Roche, biosimilars
Clock Is Ticking For AstraZeneca
Forbes
Tuesday, February 25, 2014 - 3:57pm
tags:
AstraZeneca, dulaglutide, GSK, Eli Lilly, Bydureon, diabetes
One Reason the Biotech Boom Won’t Turn to Bust
Barron's
Tuesday, February 25, 2014 - 11:17am
tags:
biotech, Biogen Idec, Regeneron
Two Years Less Exclusivity Is the Least of Amarin's Issues
Motley Fool
Tuesday, February 25, 2014 - 11:15am
tags:
Amarin, exclusivity, Vascepa
No Looking Back for Regeneron's Eylea
Yahoo/Zacks.com
Tuesday, February 25, 2014 - 11:05am
tags:
Regeneron, Eylea, BRVO
Is NPS Pharmaceuticals The Next Alexion?
Seeking Alpha
Tuesday, February 25, 2014 - 11:03am
tags:
NPS Pharmaceuticals, Alexion, NPSP795, Gattex
Wright Medical Group Sees Wider Q4 Loss
Yahoo/Zacks.com
Tuesday, February 25, 2014 - 11:00am
tags:
earnings, Wright Medical
Zerenex For The Treatment Of Hyperphosphatemia: A New Use For An Old Compound
Seeking Alpha
Tuesday, February 25, 2014 - 10:59am
tags:
hyperphosphatemia, Zerenex, Keryx
DARA BioSciences' KRN5500 Receives Orphan Drug Designation From FDA
Yahoo/Benzinga
Tuesday, February 25, 2014 - 10:51am
tags:
DARA Biosciences, KRN5500, FDA, orphan drugs, chronic chemotherapy-induced peripheral neuropathy
Endocyte's Q4 Loss Narrower than Expected
Yahoo/Zacks.com
Tuesday, February 25, 2014 - 10:49am
tags:
Endocyte, earnings
FDA approves Bristol-Myers drug for rare body fat disorder
Yahoo/Reuters
Tuesday, February 25, 2014 - 10:47am
tags:
FDA, Bristol-Myers Squibb, lipodystrophy, Myalept
Novartis looks for businesses to achieve scale, WSJ reports
Yahoo/Fly on the Wall
Tuesday, February 25, 2014 - 8:47am
tags:
Novartis, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.